Bayer HealthCare AG - Strategic SWOT Analysis Review

Date: April 29, 2015
Pages: 58
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B86053DFB16EN
Leaflet:

Download PDF Leaflet

Bayer HealthCare AG - Strategic SWOT Analysis Review
Bayer HealthCare AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

SCOPE
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
HIGHLIGHTS

Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It undertakes the design, research, development, manufacture and sale of medical products for the healthcare industry. The company develops innovative products such as animal healthcare products, consumer care products, blood glucose monitoring systems, diagnostic imaging products, cancer products and primary care products. Its general medicine primarily includes cardiovascular health and women’s healthcare products; and specialty medicine including medicines that are principally prescribed by specialist physicians. Bayer Healthcare’s products are marketed across the world through regional and national distribution companies. Bayer Healthcare is headquartered in Leverkusen, Germany.

Bayer Healthcare focuses on enhancing its market share through strategic alliances and acquisitions. In line with this strategy, the company recently collaborated with Broad Institute of MIT and Harvard to develop therapies for cardiovascular disease.

Bayer HealthCare AG Key Recent Developments

Apr 23, 2015: Manchester joins European consortium to develop liquid biopsies
Apr 15, 2015: Bayer to Present New Data on Advancing Oncology Portfolio
Feb 19, 2015: Olivier Brandicourt to leave Bayer HealthCare
Feb 17, 2015: ALT-GIST opens first Australian site
Feb 09, 2015: Bayer HealthCare's Bayer Aspirin Launches The ProHeart Path Tool to Assess CV Event Risk

REASONS TO BUY
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Bayer HealthCare AG - Key Facts
Bayer HealthCare AG - Key Employees
Bayer HealthCare AG - Key Employee Biographies
Bayer HealthCare AG - Major Products and Services
Bayer HealthCare AG - Medical Equipment Pipeline Products Data
Bayer HealthCare AG Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Development Stage
Bayer HealthCare AG - History
Bayer HealthCare AG - Company Statement
Bayer HealthCare AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Bayer HealthCare AG - Key Manufacturing Facilities
Joint Venture
BusinessUnit

SECTION 2 – COMPANY ANALYSIS

Bayer HealthCare AG - Business Description
Business Description - Animal Health
Animal Health - Overview
Animal Health - Financials
Business Description - Consumer Care
Consumer Care - Overview
Consumer Care - Financials
Business Description - Medical Care
Medical Care - Overview
Medical Care - Financials
Medical Care - Market View
Business Description - Pharmaceuticals
Pharmaceuticals - Overview
Pharmaceuticals - Financials
Pharmaceuticals - Market View
Bayer HealthCare AG - Corporate Strategy
Bayer HealthCare AG - SWOT Analysis
SWOT Analysis - Overview
Bayer HealthCare AG - Strengths
Strength - Wide Range of Products
Strength - Strong Market Position
Strength - Focused Research and Development Activities
Bayer HealthCare AG - Weaknesses
Weakness - Adverse Reactions: Xarelto
Weakness - Product Recall
Weakness - Decline in Revenue from Medical Devices
Bayer HealthCare AG - Opportunities
Opportunity - New Product Approvals and Launches
Opportunity - Strategic Agreements
Bayer HealthCare AG - Threats
Threat - Growing Parallel Trade
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Bayer HealthCare AG - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Bayer HealthCare AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bayer HealthCare AG, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Bayer HealthCare AG, Medical Equipment, Deals By Year, 2009 to YTD 2015
Bayer HealthCare AG, Medical Equipment, Deals By Type, 2009 to YTD 2015
Bayer HealthCare AG, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Apr 15, 2015: Bayer to Present New Data on Advancing Oncology Portfolio
Feb 19, 2015: Olivier Brandicourt to leave Bayer HealthCare
Feb 09, 2015: Bayer HealthCare's Bayer Aspirin Launches The ProHeart Path Tool to Assess CV Event Risk
Jan 29, 2015: Bayer to Present New Hemophilia Treatment Data at EAHAD 2015
Jan 05, 2015: FDA approves Bayer’s Gadavist injection as the first magnetic resonance contrast agent for pediatric patients less than 2 years of age
Oct 24, 2014: Bayer Forms Alliance with Kyoto University in Japan
Oct 14, 2014: Compugen Achieves Second Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer
Oct 13, 2014: Bayer Supports World Thrombosis Day as Founding Global Partner
Jun 26, 2014: Bayer and HealthyWomen Launch Family Size Matters to Help Raise Awareness of Family Planning for Women Who are Done Having Children
Jun 23, 2014: Bayer HealthCare and Dimension Therapeutics to Develop Novel Gene Therapy for Hemophilia A

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Bayer HealthCare AG, Key Facts
Bayer HealthCare AG, Key Employees
Bayer HealthCare AG, Key Employee Biographies
Bayer HealthCare AG, Major Products and Services
Bayer HealthCare AG Number of Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Equipment Type
Bayer HealthCare AG Number of Pipeline Products by Development Stage
Bayer HealthCare AG Pipeline Products by Development Stage
Bayer HealthCare AG, History
Bayer HealthCare AG, Other Locations
Bayer HealthCare AG, Subsidiaries
Bayer HealthCare AG, Key Manufacturing Facilities
Bayer HealthCare AG, Joint Venture
Bayer HealthCare AG, BusinessUnit
Bayer HealthCare AG, Key Competitors
Bayer HealthCare AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bayer HealthCare AG, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Bayer HealthCare AG, Medical Equipment, Deals By Year, 2009 to YTD 2015
Bayer HealthCare AG, Medical Equipment, Deals By Type, 2009 to YTD 2015
Bayer HealthCare AG, Recent Deals Summary

LIST OF FIGURES

Bayer HealthCare AG Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Development Stage
Bayer HealthCare AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bayer HealthCare AG, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Bayer HealthCare AG, Medical Equipment, Deals By Year, 2009 to YTD 2015
Bayer HealthCare AG, Medical Equipment, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Bayer HealthCare AG - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: